Coloplast A/s Class B · OMXCOP:COLO_B

Coloplast A/s Class B — Q1 2015/16 Earnings Presentation

7 slides from Coloplast A/s Class B's earnings presentation, Feb 2, 2016

  1. Slide 1: Coloplast Earnings Conference Call Q1 2015/16

    NEW! SenSura® Mio Convex Coloplast Earnings Conference Call Q1 2015/16 2 February 2016

  2. Slide 2: Forward-looking statements

    Forward-looking statements The forward-looking statements contained in this presentation, including forecasts of sales and earnings performance, are not guarantees of future results and are subject to risks, uncertainties and assumptions that are difficult to predict. The forward-looking statements

  3. Slide 3: Q1 organic growth of 7% and 33% EBIT margin in line with expectations in a market growing approximately 5%

    Q1 organic growth of 7% and 33% EBIT margin in line with expectations in a market growing approximately 5% Highlights Performance  Organic revenue growth of 7% (11% in Revenue (mDKK) DKK) Organic growth (%)  Gross margin of 69% on par with last year  EBIT margin of 33% on par with last year 7,000

  4. Slide 4: Q1 performance supported by a return to growth for UK homecare company Charter

    Q1 performance supported by a return to growth for UK homecare company Charter Q1 15/16 revenue by business area Q1 15/16 revenue by geography Business Reported revenue Organic growth Geographic Reported revenue Organic growth area mDKK In percent area mDKK In percent Ostomy European 5% 1,469 8% 2,3

  5. Slide 5: Operating margin of 33% impacted by efficiency gains, higher Emerging markets costs and increased R&D activity

    Operating margin of 33% impacted by efficiency gains, higher Emerging markets costs and increased R&D activity Comments Performance  Gross margin of 69% on par with last year EBIT (mDKK)  Driven by continued efficiency gains EBIT margin (%)  Offset by higher costs in Emerging markets and higher i

  6. Slide 6: Revised financial guidance in DKK for 2015/16

    Revised financial guidance in DKK for 2015/16 Guidance Guidance Long term 15/16 15/16 (DKK) ambition Sales growth 7-8% (organic) ~7% 7-10% p.a. EBIT margin 33-34% (fixed) ~33% +50-100 bps p.a. CAPEX (DKKm) ~700 ~4-5% of sales Tax rate ~23% - Page 6

  7. Slide 7: Our mission, values and vision

    Our mission Making life easier for people with intimate healthcare needs Our values Closeness… to better understand Passion… to make a difference Respect and responsibility… to guide us Our vision Setting the global standard for listening and responding Page 7

Coloplast — Q1 2015/16 Earnings Presentation on 6ix